Abstract
For pneumococcal disease surveillance, simple and cost-effective methods capable of determining all serotypes are needed. Combining a single-tube multiplex PCR with fluorescently labeled primers followed by amplicon analysis using automated fluorescent capillary electrophoresis, each serotype of 92 reference isolates and 297 recently collected clinical isolates was successfully determined.
TEXT
Streptococcus pneumoniae is a major human pathogen responsible for a wide variety of infections, from colonization and mild disease, such as sinusitis or otitis, to more-severe and life-threatening infections, such as invasive pneumonia or meningitis. The capsular polysaccharide is considered a major virulence factor in pneumococcal disease, with the composition, order, and linkage of the monosaccharides that make up the capsule determining a specific antigenic response that classifies pneumococci in different serotypes (1). It has long been known that antibodies against capsular polysaccharides are serotype specific and protective (2), and pneumococcal conjugate vaccines (PCVs), which included the polysaccharides of a limited number of serotypes, were developed to prevent pneumococcal diseases in young children. The introduction of PCVs was accompanied by a decrease in the incidence of invasive pneumococcal diseases but also by a change in the distribution of circulating serotypes (3, 4).
Knowing which S. pneumoniae serotypes cause infection is crucial in the surveillance of pneumococcal disease. Surveillance studies usually comprise many isolates, so techniques are needed that can type a large number of isolates simply and accurately. Among the developed techniques, and following the description of genes encoding the pneumococcal capsule (the cps gene cluster) by the Sanger Institute (http://www.sanger.ac.uk/Projects/S_pneumoniae/CPS/), are different PCR-based strategies. Those performed in a single PCR normally detect a limited number of serotypes (5–7), whereas those detecting more serotypes usually require 3 to 8 multiplex PCRs that are performed simultaneously (8) or sequentially (9–14), real-time multiplex PCR (15), or the combination of conventional and real-time PCR (16).
By use of multiplex PCR combined with fragment analysis using automated fluorescent capillary electrophoresis (FAF-mPCR), Lawrence et al. (17) detected 5 serotypes and 3 serogroups, whereas Selva et al. (18) identified 68 pneumococcal serotypes by multiplexing 40 pairs of primers in a unique reaction that was cost-effective in terms of reagent costs and labor time requirements. The primers used in the work of Selva et al. were those available on the CDC website (http://www.cdc.gov/streplab/downloads/pcr-oligonucleotide-primers.pdf).
In the present work using a similar strategy, we designed a single-tube multiplex PCR with 55 fluorescently labeled pairs of primers to identify 92 capsular serotypes described up to 2010 (19) (see PCR mix preparation, amplification conditions, and readout in the supplemental material). The design of the primers for the multiplex PCR was performed so that the size of two consecutive amplicons representing two different serotypes differed by ∼10 bp (range, 8 to 22 bp). Expected amplicons were arranged by size, from 84 to 650 bp, and forward primers were alternatively 5′ end labeled with three different dyes (FAM, HEX, NED). Consequently, two consecutive amplicons labeled with the same fluorescent dye had a size difference of ∼30 bp (range, 20 to 48 bp), easily distinguished by capillary electrophoresis (Table 1).
TABLE 1.
Sequences of the 55 primer pairs included in the pneumococcal serotyping multiplex PCR
| Serotype | Amplicon size (bp) | Forward primer | Forward primer sequence (5′ to 3′) | 5′ Label | Reverse primer | Reverse primer sequence (5′ to 3′) | No. of serotypes detected |
|---|---|---|---|---|---|---|---|
| 14 | 84 | Csp-14-fw | CCGTCTTTTTGTATGGTGCTATG | HEX | Csp-14-rv | TGAACAGCCAATCCATCAATCAG | 1 |
| 8 | 94 | Csp-8-fw | ATTAGCTGCATACGCAAGAACC | NED | Csp-8-rv | GTTAATCCCCAAATAGGATCCC | 1 |
| 7B, 7C, 40 | 101 | Csp-7BC40-fw | TTATTTTTTAGAAACATTAAAACTC | FAM | Csp-7BC40-rv | AACAATCATCTCTATTCGACC | 3 |
| 9L, 9N | 111 | Csp-9LV-fw | CACTGTTGGCTATGTTAGCCTC | HEX | Csp-9LV-rv | CTCTCCACGTGGCCAATATAC | 2 |
| 21 | 122 | Csp-21-fw | TTATGCTGGTTTAAATATCGCTCC | NED | Csp-21-rv | TAACAAATATGCCAAAACGTAGCC | 1 |
| 34 | 130 | Csp-34-fw | TGTAAGAGGAGATTATTTTCACCC | FAM | Csp-34-rv | GTCACAATAAAAACTGTACCTCC | 1 |
| 25A, 25F, 38 | 140 | Csp-25AF38-fw | CAACACAATGTCTTATTGCAGCC | HEX | Csp-25AF38-rv | AACGCACCCCAAAATAACTTTCC | 3 |
| 10A, 10B, 10C, 10F | 151 | Csp-10-fw | CRATGAGGCTATATGTTGGAATAG | NED | Csp-10-rv | GTATTGAACYCATAGATAACAGAG | 4 |
| 43 | 160 | Csp-43-fw | GGAATAGTTTAGGATTTGTACACC | FAM | Csp-43-rv | TAGAGTCTGCTAACTGTAATATCC | 1 |
| 9A, 9V | 172 | Csp-9AV-fw | GATCAATGGCAACTATATTTACCC | HEX | Csp-9AV-rv | GATTCACTGTCTGACTTTGAACC | 2 |
| 22A, 22F | 181 | Csp-22-fw | ACGTATAGGACGTTTCTCAATCC | NED | Csp-22-rv | ATCCCGAAACCAAATTGCTATCC | 2 |
| 3 | 191 | Csp-3-fw | AGAAATGCTATCCGCGTTGGG | FAM | Csp-3-rv | TTGTCACGAGATTACGCTCAGG | 1 |
| 15B, 15C | 201 | Csp-15BC-fw | CGGATGATTGTAGCGTTTTATCC | HEX | Csp-15BC-rv | ACTGTAGATTGTGTTCTGATTCC | 2 |
| 6A, 6B, 6C, 6D | 211 | Csp-6-fw | GAAGTAGAAAATCGTGTAAGTGG | NED | Csp-6-rv | TCCAACAACTAACCTTATAAGGG | 4 |
| 18A, 18B, 18C, 18F | 220 | Csp-18-fw | AGTCTTACTAGACGTAATGAACC | FAM | Csp-18-rv | AAGATAAATTGACTAAGTCCTCCC | 4 |
| 36 | 230 | Csp-36-fw | TTCCGGATCTATTCAATTTCCCC | HEX | Csp-36-rv | CAATAACAGCCTCCGTTTTACC | 1 |
| 27 | 240 | Csp-27-fw | AATGCCGACGATTAATGCAGCC | NED | Csp-27-rv | CTAGCCATGCTGGATATTTCCC | 1 |
| 29 | 251 | Csp-29-fw | TGTGGCAAAAATTTCTTTAGCGG | FAM | Csp-29-rv | ATATACCCAGTAAACAGACAAGG | 1 |
| 23F | 260 | Csp-23F-fw | TTCACAAGTGATAGTGAACTTGG | HEX | Csp-23F-rv | TATTAGCTTTATCGGTAAGGTGG | 1 |
| 19A | 269 | Csp-19A-fw | ATTGGAGTAGCTGAGGTTTTTGG | NED | Csp-19A-rv | TATCCAATTTAAAACCAGCACGG | 1 |
| 33C | 278 | Csp-33C-fw | CGGCAGGTATAAGTATTATCGG | FAM | Csp-33C-rv | CCTACACCTCTTATAAACGTTGG | 1 |
| 20 | 292 | Csp-20-fw | TATTGTTCCGAAAAAAGAGTGGG | HEX | Csp-20-rv | TACTCAAAGATTGTGTGGTACGG | 1 |
| 31 | 301 | Csp-31-fw | TTTCAAGGATATGATAGTGGTGG | NED | Csp-31-rv | TAGCATTACAGATGTCACTAAGG | 1 |
| 23A | 314 | Csp-23A-fw | CTAGGTTCGTATCTCTTTGCGG | FAM | Csp-23A-rv | TACCAAATGGGTAATGGAGGGG | 1 |
| 13 | 328 | Csp-13-fw | TTAACAGGTAGATTACGACTTGG | HEX | Csp-13-rv | ATATCCCAAAAACAAAATCGCTGG | 1 |
| 19B, 19C | 338 | Csp-19BC-fw | TCAGTACGAATAGATGGAACACC | NED | Csp-19BC-rv | CCCAGTATCTAAATCCTAATCCC | 2 |
| 11A, 11D, 11F | 348 | Csp-11ADF-fw | GGACATGTTCAGGTGATTTCCC | FAM | Csp-11ADF-rv | TGCGCCAAATTTGGTATCGACC | 3 |
| 32A, 32F | 357 | Csp-32-fw | CTTACAATGAGACGCTATTTTCC | HEX | Csp-32-rv | GTTATTACCATTGAATTCGTTCCC | 2 |
| 35A, 35C, 42 | 367 | Csp-35AC42-fw | TCGTTCACCTACTTTATTAATGCC | NED | Csp-35AC42-rv | AATAATTCCTAATACCATCTGCCC | 3 |
| 35F, 47F | 375 | Csp-35F47F-fw | TTGCTACAGTTTTGATGTATCTCC | FAM | Csp-35F47F-rv | AGAATCCGTTTCATCATACAGCC | 2 |
| 2 | 383 | Csp-2-fw | GTTCAATATTTCTCCACTACACC | HEX | Csp-2-rv | CTAAGAGTTCCAATACGTTGACC | 1 |
| 11B, 11C | 392 | Csp11BC-fw | TAGAAATCGCAAGATAGCCTTCC | NED | Csp11BC-rv | CTGATTATGAGCATAGTTGATCC | 2 |
| 17F | 402 | Csp-17F-fw | TCTTGTCAAATACATACTTACCCC | FAM | Csp-17F-rv | GTAGTCTCGCATTTCTATCATCC | 1 |
| 41A, 41F | 413 | Csp-41-fw | AGTTACTGGCCCTTTCTTATTCC | HEX | Csp-41-rv | AGGTAAAAAGTCATATCCATTCCC | 2 |
| 47A | 423 | Csp-47A-fw | AATACATTGTACGTCTTTAACCCC | NED | Csp-47A-rv | CGAAGAATTAAACCCACATAACC | 1 |
| 4 | 433 | Csp-4-fw | ATTCAGAGGCAGCTAGTTCAGG | FAM | Csp-4-rv | CAGAAGCTACTGTTAGGCTGG | 1 |
| 5 | 443 | Csp-5-fw | TTATCTATTTTATCGCAGACTCCC | HEX | Csp-5-rv | CTGCCGATAAAAAGATAGATGCC | 1 |
| 33A, 33F, 37 | 453 | Csp-33AF37-fw | ATGTTAGATTAGATGGTTTGCTGG | NED | Csp-33AF37-rv | ATTCAACACATAAACCGTTGGGG | 3 |
| 45 | 463 | Csp-45-fw | CAGATTGGTTTTCACATCACTCC | FAM | Csp-45-rv | ACATAACACGACTTTTAGTGACC | 1 |
| 6C, 6D | 473 | Csp-6CD-fw | GTCGTGTAAAGTAGTATACAATCC | HEX | Csp-6CD-rv | ATAATCCTCTGGATTATCCACCC | 2 |
| 35B | 483 | Csp-35B-fw | CATTAGTGTTGCTATGTTGTTCC | NED | Csp-35B-rv | GATTAGATAAATAAATACGCCCCC | 1 |
| 7A, 7F | 491 | Csp-7AF-fw | TTGACTGCAAGTGTTTCAATGGG | FAM | Csp-7AF-rv | AAAGCACAAAATATTGGAACGAGG | 2 |
| 16A | 501 | Csp-16A-fw | GTTATGATAATGGTAACGCCTCC | HEX | Csp-16A-rv | CAGCCAATAAGTCATATACGCC | 1 |
| 19F | 523 | Csp-19F-fw | TGTTCTTAGTAATGGATATACGGG | NED | Csp-19F-rv | AAAACTTCACCAGGATCTAATGG | 1 |
| 48 | 532 | Csp-48-fw | CCCTTTGATAGCTATAGTATCGG | FAM | Csp-48-rv | CCCTGGAATAGAAGTTTTCTAGG | 1 |
| 39 | 544 | Csp-39-fw | TATGAGGTATCATTTAGCAGGGG | HEX | Csp-39-rv | ATCATCGAAATGGCAACTAAAGG | 1 |
| 1 | 555 | Csp-1-fw | TTTGCTAGATGGTGAGTTTGTATC | NED | Csp-1-rv | TTTAGAAGCTGCATTGTACTACTC | 1 |
| 24A, 24B, 24F | 569 | Csp-24-fw | TCATGCTTATGTTATGTGTTACGG | FAM | Csp-24-rv | GTGAGAGCTATATTTAGAACATGG | 3 |
| 28A, 28F | 578 | Csp-28-fw | AGGTAGACTACCAATTTCAATTCC | HEX | Csp-28-rv | TACACCTGCTAATATCAATGTTCC | 2 |
| 15A, 15F | 598 | Csp-15AF-fw | ATGAGAGGAAGATATATACTGGG | NED | Csp-15AF-rv | AAATAAGTTGTCCCATAGGAAGG | 2 |
| 16F | 606 | Csp-16F-fw | ACTGCTTGCATATTAGCTTTATGG | FAM | Csp-16F-rv | TGATAGAGTGACAGAACAATTGG | 1 |
| 17A | 615 | Csp-17A-fw | TTTACCCAAGAATGGTTTCTAGG | HEX | Csp-17A-rv | AGCATAACAGTTTGCGCTATTGG | 1 |
| 12A, 12B, 12F, 44, 46 | 627 | Csp-124446-fw | CCTTTCTGATTCGTCCAGTTCC | NED | Csp-124446-rv | AGTTGAACCAACTCCCCATCC | 5 |
| 33B, 33D | 640 | Csp-33BD-fw | ACAACAGCAATGTTGTTGTTACTC | FAM | Csp-33BD-rv | GAGAAGTAAGAGTTTTGTCATCC | 2 |
| 23B | 650 | Csp-23B-fw | TTGCATATGGATTTAATGGTGGG | HEX | Csp-23B-rv | ACCATTGCTGATAGAAGTAGAGG | 1 |
The reference isolates of the 92 serotypes tested gave 55 amplicons of the expected size, except for the reference isolate of serotype 6C (a well-characterized clinical isolate) that amplified the wciNbeta gene specific for serotypes 6C and 6D but not the common wzy gene of all serotypes of serogroup 6. Of the amplicons obtained with the 92 reference isolates, 31 identified a specific serotype, 20 serotypes of the same serogroup, and 4 serotypes of different serogroups.
The capsular serotypes of all the 297 pneumococcal clinical isolates were correctly deduced using FAF-mPCR. Of these, 187 (63%) were identified at the serotype level; of the remaining isolates, 66 (22.2%), 31 (10.5%), 4 (1.3%), and 9 (3%) gave an amplicon that comprised 2, 3, 4, or 5 serotypes, respectively (Table 2).
TABLE 2.
Serotype distribution by the Quellung reaction and identification by FAF-mPCR of 297 Streptococcus pneumoniae clinical isolates
| Serotype by Quellung | No. of isolates | Serotype by FAF-mPCR |
|---|---|---|
| 1a | 17 | 1 |
| 3a | 43 | 3 |
| 4 | 2 | 4 |
| 6Aa | 2 | 6A/6B |
| 6C | 9 | 6C/6D |
| 7Fa | 6 | 7F/7A |
| 8 | 24 | 8 |
| 9L | 5 | 9N/9L |
| 9N | 3 | 9N/9L |
| 10A | 4 | 10F/10A/10B/10C |
| 11A | 16 | 11F/11A/11D |
| 12F | 9 | 12F/12A/12B/44/46 |
| 13 | 2 | 13 |
| 14a | 14 | 14 |
| 15A | 5 | 15F/15A |
| 15B | 9 | 15B/15C |
| 16F | 12 | 16F |
| 17F | 3 | 17F |
| 19Aa | 21 | 19A |
| 19Fa | 7 | 19F |
| 20 | 1 | 20 |
| 21 | 3 | 21 |
| 22F | 18 | 22F/22A |
| 23A | 12 | 23A |
| 23B | 6 | 23B |
| 24B | 1 | 24F/24A/24B |
| 25A | 1 | 25F/25A/38 |
| 38 | 4 | 25F/25A/38 |
| 31 | 13 | 31 |
| 33F | 6 | 33F/33A/37 |
| 33A | 3 | 33F/33A/37 |
| 33B | 1 | 33B/33D |
| 34 | 1 | 34 |
| 35B | 5 | 35B |
| 35F | 8 | 35F/47 |
| 45 | 1 | 45 |
Serotypes included in the 13-valent pneumococcal conjugate vaccine.
Since the pneumococcal capsular genes were described, there have been multiple molecular approaches to determine pneumococcal serotypes. In our work, we proved that at least 92 serotypes can be accurately determined in a single-tube multiplex PCR after establishment of their specific sizes and the colors of their fluorescent peaks. The methodology described here has been proved by other researchers to be useful for determining 68 pneumococcal serotypes (18). The limitation of this method is the need of a capillary electrophoresis system or a DNA sequencer capable of measuring the peaks of the amplicon of each serotype, which can hinder the utility of the technique. Another limitation is the inability to distinguish between serotypes with similar wzy genes, although much fewer Quellung reactions are needed to determine the specific serotypes.
On the other hand, the FAF-mPCR was faster, easier, and more objective than the Quellung reaction for pneumococcal serotyping. In addition, it was clearly cheaper, even excluding the personnel cost, which is obviously much higher in the Quellung reaction, because FAF-mPCR allowed the processing of batches of samples. The cost for one typing, adding the prices for one reaction of the 55 pairs of labeled primers (1.75 euros), multiplex PCR reactive isolates (1.25 euros), and capillary electrophoresis (1 euro), was ∼4.5 euros for each isolate, including consumables (0.5 euros). No labor costs were included in this calculation. The cost of the Quellung reaction, excluding labor costs, was estimated at ∼17 euros ($21.25) (20). Another advantage, compared to other multiplex PCR techniques, is the possibility of amplifying all serotypes in a unique PCR, which opens the door to simpler detection methods, such as hybridization, for an easier and more user-friendly technology.
Multiple studies have been and are being conducted regarding the efficacy of the PCVs, for which determination of the serotypes causing disease is imperative (21, 22). Other studies have focused on the changes in serotypes carried by children (23). In the present work, we observed that among 297 pneumococcal clinical isolates collected between 2013 and 2015, only 110 (37%) belonged to 13-valent PCV (PCV13) serotypes. In addition, as many as 36 different serotypes were detected. This heterogeneity in serotype distribution necessitates the development of simpler techniques that allow the serotyping of multiple isolates in an accurate and objective way in an era in which personnel costs have the greatest impact on the final price of the techniques.
Supplementary Material
ACKNOWLEDGMENTS
This work was supported in part by grants from the Health Department of the Basque Country Government (2009111012), the Spanish Ministry of Science and Innovation (Institute of Health Carlos III, ISCIII; PI13/01708), and the Education Department of the Basque Country Government to the UPV/EHU (IT656-13).
Footnotes
Supplemental material for this article may be found at http://dx.doi.org/10.1128/JCM.01156-16.
REFERENCES
- 1.Geno KA, Gilbert GL, Song JY, Skovsted IC, Klugman KP, Jones C, Konradsen HB, Nahm MH. 2015. Pneumococcal capsules and their types: past, present, and future. Clin Microbiol Rev 28:871–899. doi: 10.1128/CMR.00024-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Macleod CM, Hodges RG, Heidelberger M, Bernhard WG. 1945. Prevention of pneumococcal pneumonia by immunization with specific capsular polysaccharides. J Exp Med 82:445–465. doi: 10.1084/jem.82.6.445. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Weil-Olivier C, van der Linden M, de Schutter I, Dagan R, Mantovani L. 2012. Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective. BMC Infect Dis 12:207. doi: 10.1186/1471-2334-12-207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Flasche S, Van Hoek AJ, Sheasby E, Waight P, Andrews N, Sheppard C, George R, Miller E. 2011. Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study. PLoS Med 8:e1001017. doi: 10.1371/journal.pmed.1001017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.O'Halloran DM, Cafferkey MT. 2005. Multiplex PCR for identification of seven Streptococcus pneumoniae serotypes targeted by a 7-valent conjugate vaccine. J Clin Microbiol 43:3487–3490. doi: 10.1128/JCM.43.7.3487-3490.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Maataoui N, Bidet P, Doit C, De Lauzanne A, Lorrot M, Mariani-Kurkdjian P, Faye A, Bingen E. 2011. A multiplex polymerase chain reaction method for rapid pneumococcal serotype determination in childhood empyema. Diagn Microbiol Infect Dis 69:245–249. doi: 10.1016/j.diagmicrobio.2010.10.001. [DOI] [PubMed] [Google Scholar]
- 7.Coskun-Ari FF, Guldemir D, Durmaz R. 2012. One-step multiplex PCR assay for detecting Streptococcus pneumoniae serogroups/types covered by 13-valent pneumococcal conjugate vaccine (PCV13). PLoS One 7:e50406. doi: 10.1371/journal.pone.0050406. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Burckhardt I, Roemer J, Burckhardt F, Zimmermann S. 2014. Serotyping of pneumococci: evaluation of the genetic approach and performance with clinical samples. Diagn Microbiol Infect Dis 80:274–277. doi: 10.1016/j.diagmicrobio.2014.08.013. [DOI] [PubMed] [Google Scholar]
- 9.Brito DA, Ramirez M, de Lencastre H. 2003. Serotyping Streptococcus pneumoniae by multiplex PCR. J Clin Microbiol 41:2378–2384. doi: 10.1128/JCM.41.6.2378-2384.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Pai R, Gertz RE, Beall B. 2006. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol 44:124–131. doi: 10.1128/JCM.44.1.124-131.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Dias CA, Teixeira LM, Carvalho MG, Beall B. 2007. Sequential multiplex PCR for determining capsular serotypes of pneumococci recovered from Brazilian children. J Med Microbiol 56:1185–1188. doi: 10.1099/jmm.0.47347-0. [DOI] [PubMed] [Google Scholar]
- 12.Carvalho MDG, Pimenta FC, Jackson D, Roundtree A, Ahmad Y, Millar EV, O'Brien KL, Whitney CG, Cohen AL, Beall BW. 2010. Revisiting pneumococcal carriage by use of broth enrichment and PCR techniques for enhanced detection of carriage and serotypes. J Clin Microbiol 48:1611–1618. doi: 10.1128/JCM.02243-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Yun KW, Cho EY, Hong KB, Choi EH, Lee HJ. 2011. Streptococcus pneumoniae type determination by multiplex polymerase chain reaction. J Korean Med Sci 26:971–978. doi: 10.3346/jkms.2011.26.8.971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Jourdain S, Drèze PA, Vandeven J, Verhaegen J, Van Melderen L, Smeesters PR. 2011. Sequential multiplex PCR assay for determining capsular serotypes of colonizing S. pneumoniae. BMC Infect Dis 11:100. doi: 10.1186/1471-2334-11-100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Pimenta FC, Roundtree A, Soysal A, Bakir M, du Plessis M, Wolter N, von Gottberg A, McGee L, Carvalho MDG, Beall B. 2013. Sequential triplex real-time PCR assay for detecting 21 pneumococcal capsular serotypes that account for a high global disease burden. J Clin Microbiol 51:647–652. doi: 10.1128/JCM.02927-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Lang AL, McNeil SA, Hatchette TF, Elsherif M, Martin I, LeBlanc JJ. 2015. Detection and prediction of Streptococcus pneumoniae serotypes directly from nasopharyngeal swabs using PCR. J Med Microbiol 64:836–844. doi: 10.1099/jmm.0.000097. [DOI] [PubMed] [Google Scholar]
- 17.Lawrence ER, Griffiths DB, Martin SA, George RC, Hall LM. 2003. Evaluation of semiautomated multiplex PCR assay for determination of Streptococcus pneumoniae serotypes and serogroups. J Clin Microbiol 41:601–607. doi: 10.1128/JCM.41.2.601-607.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Selva L, del Amo E, Brotons P, Muñoz-Almagro C. 2012. Rapid and easy identification of capsular serotypes of Streptococcus pneumoniae by use of fragment analysis by automated fluorescence-based capillary electrophoresis. J Clin Microbiol 50:3451–3457. doi: 10.1128/JCM.01368-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Jin P, Kong F, Xiao M, Oftadeh S, Zhou F, Liu C, Russell F, Gilbert GL. 2009. First report of putative Streptococcus pneumoniae serotype 6D among nasopharyngeal isolates from Fijian children. J Infect Dis 200:1375–1380. doi: 10.1086/606118. [DOI] [PubMed] [Google Scholar]
- 20.Siira L, Kaijalainen T, Lambertsen L, Nahm MH, Toropainen M, Virolainen A. 2012. From Quellung to multiplex PCR, and back when needed, in pneumococcal serotyping. J Clin Microbiol 50:2727–2731. doi: 10.1128/JCM.00689-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Navarro Torné A, Dias JG, Quinten C, Hruba F, Busana MC, Lopalco PL, Gauci AJ, Pastore-Celentano L. 2014. European enhanced surveillance of invasive pneumococcal disease in 2010: data from 26 European countries in the post-heptavalent conjugate vaccine era. Vaccine 32:3644–3650. doi: 10.1016/j.vaccine.2014.04.066. [DOI] [PubMed] [Google Scholar]
- 22.Gaviria-Agudelo CL, Jordan-Villegas A, Garcia C, McCracken GH Jr. 2016. The effect of 13-valent pneumococcal conjugate vaccine on the serotype distribution and antibiotic resistance profiles in children with invasive pneumococcal disease. J Pediatric Infect Dis Soc :pii: piw005 Epub ahead of print. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Nunes S, Félix S, Valente C, Simões AS, Tavares DA, Almeida ST, Paulo AC, Brito-Avô A, de Lencastre H, Sá-Leão R. 2016. The impact of private use of PCV7 in 2009 and 2010 on serotypes and antimicrobial resistance of Streptococcus pneumoniae carried by young children in Portugal: comparison with data obtained since 1996 generating a 15-year study prior to PCV13 introduction. Vaccine 34:1648–1656. doi: 10.1016/j.vaccine.2016.02.045. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
